MAL2 and familial pancreatic carcinoma: The level of MAL2 transcripts is inversely correlated with resistance to these drugs, suggesting that the analysis of MAL2 levels in PAAD could be used as an indicator of the response to chemotherapy in pancreatic cancer [179].